Showing 1911-1920 of 5631 results for "".
- Increasing Surgery Volume Will Fuel Single-Use Ophthalmic Surgical Device Markethttps://modernod.com/news/increasing-surgery-volume-will-fuel-single-use-ophthalmic-surgical-device-market/2479784/According to Market Scope research, two factors will drive healthy growth in the single-use ophthalmic surgical product market over the next 5 years: an aging world population, which will lead to steady growth in ophthalmic surgeries, and rising concerns over cross-contamination. Market Sc
- New Dates Set for Vision Expo East 2021https://modernod.com/news/new-dates-for-vision-expo-east-2021/2478371/The Vision Council and Reed Exhibitions, organizers of Vision Expo, announced that Vision Expo East 2021, originally scheduled to take place from March 18–21, will now take place May 25–28, 2021 (Education: May 25–28; Exhibition: May 26–28) at the Javits Center in New York City. The date change r
- Staar Surgical Announces Leadership Changeshttps://modernod.com/news/staar-surgical-announces-leadership-changes/2482682/Staar Surgical announced that Stephen C. Farrell, current Lead Independent Director of the Staar Board of Directors, has been appointed President and CEO, effective February 26, 2025. He is replacing Tom Frinzi, current President and CEO, who will remain with the company in an advisory role
- NEI Explores Potential Impacts of Climate Change on Eye Healthhttps://modernod.com/news/nei-explores-potential-impacts-of-climate-change-on-eye-health/2481635/The National Eye Institute (NEI) convened a panel of experts on April 26, 2023, at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to discuss teye health care needs of the future, including the potential effects of a changing climate on eye health a
- Sifi Announces License Agreement with Avanzanite Bioscience for Acanthamoeba Keratitis Treatment Akantiorhttps://modernod.com/news/sifi-announces-license-agreement-with-avanzanite-bioscience-for-acanthamoeba-keratitis-treatment-akantior/2481340/Italy-based Sifi announced that it has partnered with Avanzanite Bioscience, a Dutch specialty pharmaceutical company, to exclusively commercialize and distribute Akantior (polihexanide) in 26 countries within the European Economic Area and Switzerland. Under the terms of the agreement,
- Johnson & Johnson Vision Reveals New Data on Blue-Violet Light Filtering Technology in Acuvue Oasys Max 1-Day Contact Lenseshttps://modernod.com/news/johnson-johnson-vision-reveals-new-data-on-blue-violet-light-filtering-technology-in-acuvue-oasys-max-1-day-contact-lenses/2481196/Johnson & Johnson Vision Care will present new data on the positive effects of wearing blue-violet light filtering contact lenses at the 2022 American Academy of Optometry (AAO) annual meeting in San Diego, October 26-29. "As a result of our increasingly digital
- J&J Vision Presents New Data on Myopia, IOLs, Phacoemulsification, Dry Eye Drops, Vision Science and Refractive Technologieshttps://modernod.com/news/jj-vision-presents-new-data-on-myopia-iols-phacoemulsification-dry-eye-drops-vision-science-and-refractive-technologies-at-arvo/2480839/Johnson & Johnson Vision is presenting 26 poster and podium presentations focusing on myopia, cataract, dry eye, vision science, and refractive research at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Live and Virtual Annual Meeting. Johnson & Johnson Vision poster
- Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 ASCRShttps://modernod.com/news/glaukos-technologies-featured-in-numerous-scientific-abstracts-at-the-2022-ascrs/2480788/Glaukos announced that its technologies will be featured in various scientific programming at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held April 22–26, 2022 in Washington, DC. In addition, Glaukos is sponsoring an educational symposium
- J&J Vision Presents Data Validating Improved Surgical Outcomes and Surgeon Satisfaction at ASCRShttps://modernod.com/news/johnson-johnson-vision-presents-data-validating-improved-surgical-outcomes-and-surgeon-satisfaction-across-cataract-and-refractive-portfolio-at-ascrs/2480787/Johnson & Johnson Vision will present and/or support 46 company-sponsored and investigator-led studies evaluating innovations and outcomes across its surgical portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Washington, DC, April 22-26.
- Alcon Announces Scientific Program at ASCRS 2022https://modernod.com/news/alcon-announces-scientific-program-at-ascrs-2022/2480782/Alcon will once again have a significant scientific presence at the American Society of Cataract and Refractive Surgery (ASCRS) 2022 annual meeting, taking place April 22-26 in Washington, DC. Approximately 150 abstracts feature Alcon’s leading ophthalmic products and equipment—with m